510(k) Report

FDA applicant

Autogenomics, Incorporated

Carlsbad, CA4 decisions2007–20230 recalls

FDA records 4 decisions for Autogenomics, Incorporated (Carlsbad, CA) from 2007 to 2023: 3 510(k) clearances and 1 original PMA approval. Most are in product codes NTI (Drug Metabolizing Enzyme Genotyping Systems) and NPQ (Test, Factor V Leiden Mutations, Genomic Dna Pcr). Its devices cite 4 predicates, 2 of them its own earlier devices. No recall is linked to its devices.

FDA’s records also spell it “AutoGenomics, Inc.”.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical toxicology panel, where it files most

How often FDA has decided Autogenomics, Incorporated’s devices, and how often a recall has named them.

FDA decisions per year

1in 2023

2007: 12008: 12010: 12023: 1
2007high 1 (2007) · low 0 (2009)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2007.

FIG. 1 — Autogenomics, Incorporated by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Autogenomics, Incorporated’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report